Automated insulin delivery systems have been found to not only improve HbA1c, but also to improve the percentage of time glucose is in the target range and may reduce events of hyperglycemia and hypoglycemia when compared with sensor-augmented insulin pump therapy [25,26,27]. Here, INS is linked to Hyperglycemia.